Article
Licensed
Unlicensed
Requires Authentication
Is the International Regulation of Biotechnology Coherent?
-
Catherine Rhodes
Published/Copyright:
October 5, 2009
Abstract
Coherence has an important influence on the ability of a set of international regulations to function effectively. This paper examines the degree of coherence among the international regulations relevant to applications and impacts of biotechnology, and outlines problems that may arise from a lack of coherence among this regulatory set.
Published Online: 2009-10-05
Published in Print: 2009-September
© copyright 2009 by De Gruyter Rechtswissenschaften Verlags-GmbH, Lützowstraße 33, 10785 Berlin, Germany
You are currently not able to access this content.
You are currently not able to access this content.
Articles in the same Issue
- Editorial
- Is the International Regulation of Biotechnology Coherent?
- ‘Therapeutic’, Enhancement Enabling, Assistive Devices and the UN Convention on the Rights of Persons with Disabilities: A Missing Lens in the Enhancement Regulation Discourse
- Revisiting the USPTO's Examination Guidelines for Gene Patents: Congressional Inaction, USPTO Restraint, and Judicial Remedy
- Pandemic Diseases: Pharmaceutical Drugs and Vaccines Accessibility in Brazil
- The Growing Role of Genetic Professionals in Forensic DNA
Articles in the same Issue
- Editorial
- Is the International Regulation of Biotechnology Coherent?
- ‘Therapeutic’, Enhancement Enabling, Assistive Devices and the UN Convention on the Rights of Persons with Disabilities: A Missing Lens in the Enhancement Regulation Discourse
- Revisiting the USPTO's Examination Guidelines for Gene Patents: Congressional Inaction, USPTO Restraint, and Judicial Remedy
- Pandemic Diseases: Pharmaceutical Drugs and Vaccines Accessibility in Brazil
- The Growing Role of Genetic Professionals in Forensic DNA
